Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by InTheWeeds2on Nov 25, 2020 8:09pm
330 Views
Post# 31975638

RE:RE:Bought Deal Incoming I think

RE:RE:Bought Deal Incoming I think

Retail investor here and not claiming a deep understanding but isn't there something in their books that makes it in the best interest to keep the stock price below a certain level ( around $9.0 Canadian) or there are some options that kick in. 


I may have that totally wrong but someone on this board would know. That's the risk with offering more stocks to drop the price that I am thinking about. Totally hoping for $20 ( been here since $21 a few years back). 

<< Previous
Bullboard Posts
Next >>